Lymphoproliferative Disorders

"Lymphoproliferative Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disorders characterized by proliferation of lymphoid tissue, general or unspecified.

Descriptor ID	D008232
MeSH Number(s)	C15.604.515 C20.683.515
Concept/Terms	Lymphoproliferative Disorders Lymphoproliferative Disorders Disorder, Lymphoproliferative Disorders, Lymphoproliferative Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorder Disorder, X-Linked Lymphoproliferative Disorders, X-Linked Lymphoproliferative Lymphoproliferative Disorder, X-Linked Lymphoproliferative Disorders, X-Linked X Linked Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorders Epstein-Barr Virus Infection, Familial Fatal Epstein Barr Virus Infection, Familial Fatal Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males Epstein Barr Virus Induced Lymphoproliferative Disease In Males Familial Fatal Epstein-Barr Infection Familial Fatal Epstein Barr Infection Immunodeficiency 5 Immunodeficiency 5s Duncan's Syndrome Lymphoproliferative Disease, X-Linked Disease, X-Linked Lymphoproliferative Diseases, X-Linked Lymphoproliferative Lymphoproliferative Disease, X Linked Lymphoproliferative Diseases, X-Linked X-Linked Lymphoproliferative Diseases Lymphoproliferative Syndrome, X-Linked, 1 Purtilo Syndrome Purtilo Syndromes Syndrome, Purtilo Syndromes, Purtilo X-Linked Lymphoproliferative Disease X Linked Lymphoproliferative Disease X-Linked Lymphoproliferative Syndrome Lymphoproliferative Syndrome, X-Linked Lymphoproliferative Syndromes, X-Linked Syndrome, X-Linked Lymphoproliferative Syndromes, X-Linked Lymphoproliferative X Linked Lymphoproliferative Syndrome X-Linked Lymphoproliferative Syndromes Duncan Disease Disease, Duncan Immunodeficiency, X-Linked Progressive Combined Variable Immunodeficiency, X Linked Progressive Combined Variable

Below are MeSH descriptors whose meaning is more general than "Lymphoproliferative Disorders".

Diseases [C]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]

Below are MeSH descriptors whose meaning is related to "Lymphoproliferative Disorders".

Below are MeSH descriptors whose meaning is more specific than "Lymphoproliferative Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lymphoproliferative Disorders" by people in this website by year, and whether "Lymphoproliferative Disorders" was a major or minor topic of these publications.

Bar chart showing 27 publications over 20 distinct years, with a maximum of 3 publications in 2002 and 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1996	1	0	1
1997	1	1	2
1998	1	0	1
1999	1	0	1
2000	1	0	1
2001	0	1	1
2002	1	2	3
2004	1	0	1
2006	1	0	1
2008	1	0	1
2009	2	0	2
2012	3	0	3
2013	1	0	1
2015	1	0	1
2016	1	0	1
2018	1	0	1
2019	1	0	1
2021	1	1	2
2023	1	0	1

Below are the most recent publications written about "Lymphoproliferative Disorders" by people in Profiles.

Massicotte-Azarniouch D, Detwiler RK, Hu Y, Falk RJ, Saha MK, Hogan SL, Derebail VK. Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis. Nephrol Dial Transplant. 2023 08 31; 38(9):2009-2018.

View in: PubMed
Ahmadi E, Ravanshad M, Xie J, Panigrahi R, Jubbal SS, Guru SK, Guangping G, Ziyaeyan M, Fingeroth J. Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein-Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV?+?lymphoproliferative disorders. Virol J. 2021 11 18; 18(1):223.

View in: PubMed
Sanikommu SR, Reese ES, He J, Lee C, Ai J, Butler CM, Jacobs R, Hu B, Atrash S, Trivedi J, Bhutani M, Voorhees P, Usmani SZ, Ghosh N, Fasan O, Druhan LJ, Symanowski J, Copelan EA, Avalos BR. Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation. J Clin Apher. 2021 Aug; 36(4):553-562.

View in: PubMed
Brar N, Butzmann A, Kumar J, Peerani R, Morgan EA, Grigoriadis G, Kumar B, Tatarczuch RM, Warnke RA, Ohgami RS. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations. Histopathology. 2020 Dec; 77(6):984-988.

View in: PubMed
Naik S, Riches M, Hari P, Kim S, Chen M, Bachier C, Shaughnessy P, Hill J, Ljungman P, Battiwalla M, Chhabra S, Daly A, Storek J, Ustun C, Diaz MA, Cerny J, Beitinjaneh A, Yared J, Brown V, Page K, Dahi PB, Ganguly S, Seo S, Chao N, Freytes CO, Saad A, Savani BN, Woo Ahn K, Boeckh M, Heslop HE, Lazarus HM, Auletta JJ, Kamble RT. Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study. Transpl Infect Dis. 2019 Oct; 21(5):e13145.

View in: PubMed
Garc?a-Cadenas I, Y??ez L, Jarque I, Martino R, P?rez-Sim?n JA, Valc?rcel D, Sanz J, Berm?dez A, Mu?oz C, Calder?n-Cabrera C, Garc?a E, Alonso L, Su?rez-Lled? M, Gonz?lez Vicent M, Heras I, Viguria MC, Batlle M, V?zquez L, L?pez J, Solano C. Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH). Eur J Haematol. 2019 Jun; 102(6):465-471.

View in: PubMed
Xia D, Morgan EA, Berger D, Pinkus GS, Ferry JA, Zukerberg LR. NK-Cell Enteropathy and Similar Indolent Lymphoproliferative Disorders: A Case Series With Literature Review. Am J Clin Pathol. 2019 01 01; 151(1):75-85.

View in: PubMed
Dugan JP, Haverkos BM, Villagomez L, Martin LK, Lustberg M, Patton J, Martin M, Huang Y, Nuovo G, Yan F, Cavaliere R, Fingeroth J, Kenney SC, Ambinder RF, Lozanski G, Porcu P, Caligiuri MA, Baiocchi RA. Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone. Clin Cancer Res. 2018 07 15; 24(14):3273-3281.

View in: PubMed
Nason KS, Kirchner A, Schuchert MJ, Luketich JD, Christie NA, Pantanowitz L, Karunamurthy A, Monaco SE. Endobronchial Ultrasound-Transbronchial Needle Aspiration for Lymphoma in Patients With Low Suspicion for Lung Cancer and Mediastinal Lymphadenopathy. Ann Thorac Surg. 2016 May; 101(5):1856-63.

View in: PubMed
Tai R, Tirumani SH, Tirumani H, Shinagare AB, Hornick JL, Ramaiya NH. Is there a difference in post-transplant lymphoproliferative disorder in adults after solid organ and haematologic stem cell transplantation? Experience in 41 patients. Br J Radiol. 2015 Aug; 88(1052):20140861.

View in: PubMed

People

Explore

Similar Concepts

Top Journals